Treatment of Class IV Lupus Nephritis with Mycophenolate Mofetil Monotherapy

  • Nawata Takashi
    Department of Medicine and Clinical Science, Division of Cardiology and Clinical Immunology, Yamaguchi University Graduate School of Medicine, Japan
  • Kubo Makoto
    Department of Medicine and Clinical Science, Division of Cardiology and Clinical Immunology, Yamaguchi University Graduate School of Medicine, Japan
  • Fujii Shohei
    Department of Medicine and Clinical Science, Division of Cardiology and Clinical Immunology, Yamaguchi University Graduate School of Medicine, Japan
  • Shiragami Kosaku
    Department of Medicine and Clinical Science, Division of Cardiology and Clinical Immunology, Yamaguchi University Graduate School of Medicine, Japan
  • Ikegami Tadayoshi
    Department of Medicine and Clinical Science, Division of Cardiology and Clinical Immunology, Yamaguchi University Graduate School of Medicine, Japan
  • Kobayashi Shigeki
    Department of Medicine and Clinical Science, Division of Cardiology and Clinical Immunology, Yamaguchi University Graduate School of Medicine, Japan
  • Hisano Satoshi
    Department of Pathology, Faculty of Medicine Fukuoka University, Japan
  • Yano Masafumi
    Department of Medicine and Clinical Science, Division of Cardiology and Clinical Immunology, Yamaguchi University Graduate School of Medicine, Japan

Search this article

Abstract

<p>Lupus nephritis (LN) occurs in up to 60% of systemic lupus erythematosus patients. Combination therapy involving a corticosteroid and cyclophosphamide or mycophenolate mofetil (MMF) has been a standard therapy for LN. However, clinicians generally prefer to minimize steroid use in LN treatment. We herein report the case of a Japanese man with LN whose severe chronic heart failure prevented us from using steroid therapy. Instead, his LN was successfully treated with MMF monotherapy. Based on our experience with this case, we suggest that MMF monotherapy may represent a feasible LN treatment option in patients who cannot tolerate steroid therapy. </p>

Journal

  • Internal Medicine

    Internal Medicine 57 (14), 2067-2070, 2018-07-15

    The Japanese Society of Internal Medicine

References(16)*help

See more

Related Projects

See more

Details 詳細情報について

Report a problem

Back to top